{"transactions":[{"id":776701,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":46815,"kind":"person","name":"Saltzman Edward C","position":1,"cik":"0001946233","reported_name":"Saltzman Edward C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T21:55:29.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":31250,"derivative":{"exercise_price":15.86,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001946233-26-000002","document":"wk-form4_1778882126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000194623326000002/wk-form4_1778882126.xml","form_type":"4"}},{"id":1142005,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":46815,"kind":"person","name":"Saltzman Edward C","position":1,"cik":"0001946233","reported_name":"Saltzman Edward C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-19T21:33:11.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 19, 2026, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.51,"expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001549595-25-000080","document":"wk-form4_1747690384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959525000080/wk-form4_1747690384.xml","form_type":"4"}},{"id":1508599,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":46815,"kind":"person","name":"Saltzman Edward C","position":1,"cik":"0001946233","reported_name":"Saltzman Edward C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-05-20T23:25:10.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 20, 2025, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":16.19,"expiration_date":"2034-05-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001549595-24-000064","document":"wk-form4_1716247500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959524000064/wk-form4_1716247500.xml","form_type":"4"}},{"id":1904070,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":46815,"kind":"person","name":"Saltzman Edward C","position":1,"cik":"0001946233","reported_name":"Saltzman Edward C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-04T23:58:58.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 4, 2024, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.44,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-027512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000120919123027512/doc4.xml","form_type":"4"}},{"id":2159141,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":46815,"kind":"person","name":"Saltzman Edward C","position":1,"cik":"0001946233","reported_name":"Saltzman Edward C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-09-14T20:25:30.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning October 12, 2022 until the option is fully vested on September 12, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":16.29,"expiration_date":"2032-09-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-049924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000120919122049924/doc4.xml","form_type":"4"}}]}